According to a recent report in Pharma Times, the National Institute for Health and Care Excellence (NICE) in the UK is recommending coverage of treatment with radium-223 dichoride (Xofigo) but has changed its mind about coverage of degarelix (Firmagon). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: advanced, Degarelix, Firmagon, metastatic, NICE, radium-223, UK, Xofigo | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 